Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes

References

• FurlanettoRLAndreoEGFinottiIGEpidemiology and etiologic diagnosis of infectious keratitis in Uberlandia, BrazilEur J Ophthalmol20102049850320175055
   PubMed Web of Science ®Google Scholar
• CarielloAJPassosRMYuMCMicrobial keratitis at a referral center in BrazilInt Ophthalmol20113119720421448786
   PubMedGoogle Scholar
• ChowdharyASinghKSpectrum of fungal keratitis in North IndiaCornea20052481515604861
   PubMed Web of Science ®Google Scholar
• XieLZhongWShiWSpectrum of fungal keratitis in north ChinaOphthalmology20061131943194816935335
   PubMed Web of Science ®Google Scholar
• IbrahimMMVaniniRIbrahimFMEpidemiologic aspects and clinical outcome of fungal keratitis in southeastern BrazilEur J Ophthalmol20091935536119396778
   PubMed Web of Science ®Google Scholar
• Hofling-LimaALForsetoADupratJPLaboratory study of the mycotic infectious eye diseases and factors associated with keratitisArq Bras Oftalmol200568212715824799
   PubMedGoogle Scholar
• GodoyPCanoJGeneJGenotyping of 44 isolates of Fusarium solani, the main agent of fungal keratitis in BrazilJ Clin Microbiol2004424494449715472299
   PubMed Web of Science ®Google Scholar
• O’DonnellKSarverBABrandtMPhylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated US keratitis outbreaks of 2005 and 2006J Clin Microbiol2007452235224817507522
   PubMed Web of Science ®Google Scholar
• OechslerRAFeilmeierMRLedeeDUtility of molecular sequence analysis of the ITS rRNA region for identification of Fusarium spp. from ocular sourcesInvest Ophthalmol Vis Sci2009502230223619136697
   PubMed Web of Science ®Google Scholar
• ChenAPrajnaLSrinivasanMDoes in vitro susceptibility predict clinical outcome in bacterial keratitis?Am J Ophthalmol200814540941218207124
   PubMed Web of Science ®Google Scholar
• LalithaPSrinivasanMManikandanPRelationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitisClin Infect Dis2012541381138722447793
   PubMed Web of Science ®Google Scholar
• KayeSTuftSNealTBacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitisInvest Ophthalmol Vis Sci20105136236819684005
   PubMed Web of Science ®Google Scholar
• PradhanLSharmaSNalamadaSNatamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolatesIndian J Ophthalmol20115951251422011503
   PubMed Web of Science ®Google Scholar
• LalithaPPrajnaNVOldenburgCEOrganism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trialCornea20123166266722333662
   PubMed Web of Science ®Google Scholar
• ShapiroBLLalithaPLohARSusceptibility testing and clinical outcome in fungal keratitisBr J Ophthalmol20109438438520215380
   PubMed Web of Science ®Google Scholar
• ScottIUScheinODWestSFunctional status and quality of life measurement among ophthalmic patientsArch Ophthalmol19941123293358129657
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards InstituteReference method for broth dilution antifungal susceptibility testing of filamentous fungiApproved Standard M38-A22nd edWayne, PAClinical and Laboratory Standards Institute2008
   Google Scholar
• TamuraKDudleyJNeiMMEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0Mol Biol Evol2007241596159917488738
   PubMed Web of Science ®Google Scholar
• PosadaDjModelTest: phylogenetic model averagingMol Biol Evol2008251253125618397919
   PubMed Web of Science ®Google Scholar
• HuelsenbeckJPRonquistFMRBAYES: Bayesian inference of phylogenetic treesBioinformatics20011775475511524383
   PubMed Web of Science ®Google Scholar
• MaddisonDRTesting monophyly of a group of beetlesStudy 1 in Mesquite: a modular system for evolutionary analysis, version 1.042004 Available from: http://mesquiteproject.org/mesquite2.0/Mesquite_Folder/docs/mesquite/studies/study001/index.htmlAccessed June 19, 2013
   Google Scholar
• LalithaPVijaykumarRPrajnaNVIn vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powderJ Clin Microbiol2008463477347818701666
   PubMed Web of Science ®Google Scholar
• WongTYNgTPFongKSRisk factors and clinical outcomes between fungal and bacterial keratitis: a comparative studyCLAO J1997232752819348453
   PubMedGoogle Scholar
• OechslerRAFeilmeierMRMillerDFusarium keratitis: genotyping, in vitro susceptibility and clinical outcomesCornea20133266767323343947
   PubMed Web of Science ®Google Scholar
• MukherjeePKChandraJYuCCharacterization of Fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesisInvest Ophthalmol Vis Sci2012534450445722669723
   PubMed Web of Science ®Google Scholar
• AlfonsoECCantu-DibildoxJMunirWMInsurgence of Fusarium keratitis associated with contact lens wearArch Ophthalmol200612494194716769827
   PubMed Web of Science ®Google Scholar
• IyerSATuliSSWagonerRCFungal keratitis: emerging trends and treatment outcomesEye Contact Lens20063226727117099386
   PubMedGoogle Scholar
• RitterbandDCSeedorJAShahMKFungal keratitis at the New York Eye and Ear InfrmaryCornea20062526426716633023
   PubMed Web of Science ®Google Scholar
• TanureMACohenEJSudeshSSpectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, PennsylvaniaCornea20001930731210832689
   PubMed Web of Science ®Google Scholar
• KeayLJGowerEWIovienoAClinical and microbiological characteristics of fungal keratitis in the United States, 2001–2007: a multicenter studyOphthalmology201111892092621295857
   PubMed Web of Science ®Google Scholar
• RautarayaBSharmaSKarSDiagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern IndiaBMC Ophthalmol201111394622188671
   PubMed Web of Science ®Google Scholar
• Espinel-IngroffAIn vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogensJ Clin Microbiol1998361982029431946
   PubMed Web of Science ®Google Scholar
• Espinel-IngroffABoyleKSheehanDJIn vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literatureMycopathologia200115010111511469757
   PubMed Web of Science ®Google Scholar
• MarangonFBMillerDGiaconiJAIn vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogensAm J Ophthalmol200413782082515126145
   PubMed Web of Science ®Google Scholar
• ReubenAAnaissieENelsonPEAntifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution methodAntimicrob Agents Chemother198933164716492817867
   PubMed Web of Science ®Google Scholar
• TortoranoAMPrigitanoADhoGSpecies distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern ItalyAntimicrob Agents Chemother2008522683268518443107
   PubMed Web of Science ®Google Scholar
• WangHXiaoMKongFAccurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility studyJ Clin Microbiol2011491890189821389150
   PubMed Web of Science ®Google Scholar
• O’DayDMHeadWSRobinsonRDCorneal penetration of topical amphotericin B and natamycinCurr Eye Res198658778823490954
   PubMed Web of Science ®Google Scholar